When should a lab manager consider investing in automation?

Laboratory managers face a recurring question that never quite goes away: is the current workflow good enough, or is it quietly costing the lab more than it should? For labs handling environmental contaminant analysis, including dioxins, PCBs, PFAS, and pesticides, the pressure to produce accurate, high-volume results under tightening regulatory conditions makes this question increasingly urgent. Laboratory automation is no longer a luxury reserved for large reference laboratories. In 2026, it represents a practical, often necessary step for any lab serious about throughput, data quality, and long-term sustainability.

Knowing when to invest, however, is just as important as knowing what to invest in. The decision involves more than budget. It requires an honest assessment of where manual processes are creating friction, where regulatory risk is accumulating, and what the true cost of standing still looks like.

Signs your current workflow is holding the lab back

Workflow bottlenecks rarely announce themselves clearly. They tend to accumulate gradually, showing up as missed deadlines, inconsistent results, or technicians spending disproportionate time on repetitive, low-skill tasks. When these patterns become routine rather than exceptional, they signal that the current setup has reached its ceiling.

One of the clearest early indicators is analyst fatigue in sample preparation. Manual extraction and cleanup procedures for persistent organic pollutants are technically demanding and time-consuming. When the same personnel are responsible for both sample preparation and data interpretation, quality in one area inevitably suffers. A second warning sign is variability in results between analysts or between runs, which points to the inherent inconsistency of manual technique rather than an analytical instrument problem. If inter-laboratory comparisons or proficiency testing results are trending downward, the sample preparation stage is often the source.

Solvent handling is another telling indicator. Labs managing large volumes of dichloromethane and other organic solvents face real health, safety, and disposal costs that compound over time. When solvent consumption per sample is high and waste management is becoming a logistical burden, the workflow itself is generating costs that automation could substantially reduce. These operational friction points, taken together, are a strong signal that the lab is working harder than it needs to.

How sample volume and throughput demands drive the decision

Throughput pressure is often the most direct trigger for investing in laboratory automation. When sample intake increases, whether due to new contracts, expanded monitoring programs, or regulatory obligations, manual workflows hit a hard ceiling that cannot be overcome simply by adding staff.

The math is straightforward. A manual extraction and cleanup process for dioxin or PBDE analysis can take a full working day per batch of samples. Automated systems, by contrast, can run overnight or across weekends without supervision, effectively multiplying productive capacity without multiplying headcount. For labs pursuing PBDE analysis automation or PFAS workflows, this capacity gain is not marginal. It is transformative.

High-throughput platforms designed for solid phase extraction, such as those capable of processing dozens of samples in a single unattended run, also reduce the per-sample time investment significantly. This matters not just for productivity but for turnaround times, which are increasingly a competitive differentiator when laboratories are bidding for contracts or serving time-sensitive clients. If the lab is regularly declining sample volume because capacity is the constraint, the investment case for automation becomes very straightforward.

Regulatory compliance and data integrity as investment triggers

Regulatory frameworks governing contaminant analysis are becoming more stringent, not less. EU regulations on dioxins and PCBs in food and feed, EPA methods for PFAS in water, and evolving standards for PBDE monitoring all demand documented, reproducible procedures that can withstand audit scrutiny. Manual workflows, by their nature, introduce variability that is difficult to fully document or defend.

Automated sample preparation systems generate detailed run logs, instrument parameters, and traceable records that support the data integrity requirements of ISO 17025 accreditation. When a laboratory is preparing for an accreditation audit or responding to a regulatory inquiry, having a fully documented, automated preparation workflow is a significant advantage over relying on analyst notebooks and manual records.

Data integrity is also a practical concern beyond compliance. Errors introduced during manual sample preparation, including incorrect volumes, contaminated equipment, or cross-contamination between samples, can invalidate entire analytical runs. Automated systems that keep samples isolated from the instrument flow path eliminate cross-contamination as a variable entirely. For labs where a single failed run carries significant cost and reputational consequences, this reliability is an investment in risk management as much as efficiency.

Calculating the real cost of staying manual

The cost of not automating is rarely captured on a single line in a budget spreadsheet, but it is real and often substantial. A full accounting requires looking beyond instrument purchase prices to the total operational picture.

Consider analyst time. If a senior scientist spends three to four hours per day on sample preparation tasks that an automated system could handle overnight, that represents a significant opportunity cost. The same expertise applied to method development, data interpretation, or client consultation generates far more value for the laboratory. Staff retention is also a factor: repetitive, solvent-heavy manual work is not the environment that attracts or keeps skilled analysts in a competitive hiring market.

Solvent costs and waste disposal fees are another underestimated line item. Automated systems designed around green chemistry principles can reduce solvent consumption to under 100 ml per sample and eliminate the need for high-hazard solvents like dichloromethane. Over a year of operations, the savings in reagent costs, personal protective equipment, and hazardous waste disposal can be meaningful. Add the cost of repeat analyses caused by manual errors, and the total cost of staying manual often exceeds the capital investment in automation within a reasonable timeframe.

What to evaluate before committing to an automation system

Not every automation system suits every laboratory, and a poor fit is as costly as no automation at all. Before committing, it is worth building a structured evaluation framework around the lab’s specific analytical scope, volume profile, and physical constraints.

Sample matrix and analyte compatibility

The first question is whether the system handles the matrices and target compounds the lab actually works with. A platform optimized for water samples behaves very differently from one designed for food, feed, soil, or biological tissue. For labs running PFAS SPE automation, the flow path materials matter enormously. Systems with fully inert flow paths and no fluoropolymer components prevent PFAS contamination of blanks and standards, which is a non-negotiable requirement for low-level PFAS work.

Integration with existing instrumentation

Automation in sample preparation only delivers its full value when the prepared extracts flow smoothly into the detection step. Evaluate whether the system produces outputs, including solvent type, volume, and concentration, that are directly compatible with the lab’s GC-MS/MS or LC-MS/MS instrumentation. Systems that require additional manual concentration or solvent exchange steps between preparation and injection reduce the efficiency gains that automation is supposed to deliver.

Scalability and support

A system that meets today’s throughput needs but cannot scale as volume grows will require replacement sooner than expected. Look for platforms with modular configurations, multiple channel options, or the ability to run consecutive sequences. Equally important is the quality of after-sales support, including application development assistance, method validation support, and access to certified analytical standards. The relationship with the supplier matters as much as the instrument specification.

How DSP-Systems helps labs make the transition to automation

DSP-Systems works with environmental and food testing laboratories across Europe and North America to identify the right automated sample preparation platform for their specific analytical needs. Whether the priority is dioxin and PCB purification, PFAS extraction, or multi-contaminant workflows, the product portfolio covers the full sample preparation chain.

The GO-EHT systems from Miura provide fully automated purification for dioxins, PCBs, PBDEs, and PCNs across food, feed, soil, water, and air matrices, with solvent consumption below 100 ml per sample and no cross-contamination risk
The SPE2000 supports up to 80 samples per run with compatibility across 1 ml to 12 ml cartridges, suited for PFAS, pesticides, hormones, PAHs, and other emerging contaminants
The AutoEmpore handles large-volume water extraction in parallel or series mode, with automatic online filtration for PFAS and pesticide analysis
The SER-158 extractor integrates directly with GO-EHT systems for a complete, end-to-end automated workflow from solid sample extraction through cleanup
Method development, validation support, and training are available to help labs become operational quickly and maintain accreditation requirements

If the signs described in this article sound familiar, it may be time to explore what a purpose-built laboratory automation supplier can offer. Contact DSP-Systems to discuss which system fits the lab’s analytical scope, throughput targets, and regulatory obligations.